Clinical Trial Update: Blood Test (Guardant Shield™) for Screening of Colorectal Cancer in Underserved Patients

View source ↗

Summary

A completed clinical trial evaluating the Guardant Shield blood test for colorectal cancer screening in underserved patients (NCT05716477).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Guardant Shield

Snippet

Sponsor: Ohio State University Comprehensive Cancer Center | Conditions: Colorectal Carcinoma | Status: COMPLETED